A Review of Safety, Efficacy, and Utilization of Erythropoietin, Darbepoetin, and Peginesatide for Patients with Cancer or Chronic Kidney Disease: A Report from the Southern Network on Adverse Reactions (SONAR)

The erythropoiesis-stimulating agents (ESAs) erythropoietin and darbepoetin prevent transfusions among chemotherapy-associated anemia patients. Clinical trials, meta-analyses, and guidelines identify mortality, tumor progression, and venous thromboembolism (VTE) risks with ESA administration in this...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bennett, Charles L., Spiegel, David M., Macdougall, Iain C., Norris, LeAnn, Qureshi, Zaina P., Sartor, Oliver, Lai, Stephen Y., Tallman, Martin S., Raisch, Dennis W., Smith, Sheila Weiss, Silver, Samuel, Murday, Alanna S., Armitage, James O., Goldsmith, David
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3947540/
https://ncbi.nlm.nih.gov/pubmed/23111861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0032-1328884
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares